Kymera Therapeutics, Inc. KYMR
Set alert
127.51 USD +0.88 +0.69%
At close
126.51 -1.00 -0.78%
Pre-market · Nov 3, 7:09 AM ET
124.30 Day range 129.34
55.66 52-week range 130.05
- YTD
- +63.87%
- 1 year
- +113.51%
- Open
- 127.00
- Prev close
- 126.63
- Mkt cap
- 10.89B
- Vol
- 1.29M
- Avg vol
- 784.28K
- EPS
- -3.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 124.30
- High
- 129.34
- Forward P/E
- -25.30
- Beta
- 2.03
- Short ratio
- 10.32
- Inst. own
- 116.24%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 25, 2027
- 50-d avg
- 114.92
- 200-d avg
- 96.42
- 1y target
- 144.39
MAX chart
Events in this range
- Nov 4, 2025Earnings: -0.9; estimate -0.71; surprise -26.76%
- Feb 26, 2026Earnings: -0.97; estimate -0.78366; surprise -23.78%
- Apr 30, 2026Earnings: -0.71; estimate -0.89; surprise 20.22%
- Aug 5, 2026Earnings: -0.62; estimate -0.7126; surprise 12.99%
- Oct 9, 2026Rating: Raymond James · — → Outperform
- Oct 27, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 29, 2026Earnings: -1.32; estimate -1.26; surprise -4.76%
- Oct 29, 2026Rating: BTIG · Buy → Buy
- Oct 30, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 30, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Rating: Barclays · Overweight → Overweight
Signals (103)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| RSI: Overbought | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
Newest 20 of 103.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 144.39 +13.2% upside
Now 127.51
- Target (low)
- 112.00
- Target (mean)
- 144.39
- Target (high)
- 180.00
Ratings (0m) 24 22 buy · 2 hold · 0 sell
- Strong buy5
- Buy17
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 24
- 1 month ago 23
- 2 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.26 | -1.54 – -0.7767 | -0.98 | -28.4% | 76.92K | -97.3% | 20 |
| Next quarter | -1.32 | -1.52 – -1.01 | -0.71 | -86.2% | 8.40M | -75.6% | 6 |
| Current year | -3.88 | -4.21 – -3.13 | -3.69 | -5.2% | 99.41M | +153.5% | 21 |
| Next year | -5.04 | -6.70 – -3.36 | -3.88 | -29.9% | 42.03M | -57.7% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 29, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Raymond James | Initiated | — | Outperform |
| Oct 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 22, 2026 | Stifel | Maintained | Buy | Buy |
| Sep 14, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 10, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Aug 31, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Deutsche Bank | Initiated | — | Hold |
| Jul 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 16, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 13, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jun 30, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jun 29, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Jun 26, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 25, 2026 | BTIG | Reiterated | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Mar 3, 2026 | UBS | Maintained | Buy | Buy |
| Mar 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 2, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Feb 26, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 3, 2026 | BTIG | Reiterated | Buy | Buy |
| Jan 28, 2026 | Barclays | Maintained | Overweight | Overweight |